Article Text

other Versions

PDF
Prediction of bronchopulmonary dysplasia
  1. Caroline May1,
  2. Sabina Patel1,
  3. Caroline Kennedy1,
  4. Elena Pollina2,
  5. Gerrard F Rafferty1,
  6. Janet L Peacock3,
  7. Anne Greenough1
  1. 1Division of Asthma, Allergy and Lung Biology, MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, King's College London, London, UK
  2. 2Department of Histopathology, King's College Hospital, London, UK
  3. 3Public Health Sciences and Medical Statistics, University of Southampton, Southampton, UK
  1. Correspondence to Professor Anne Greenough, Department of Child Health, 4th Floor Golden Jubilee Wing, King's College Hospital, London SE5 9RS, UK; anne.greenough{at}kcl.ac.uk

Abstract

Objective To determine whether elevation of a biological marker of inflammation would be a better predictor of bronchopulmonary dysplasia (BPD) development than lung function measurement results.

Design Prospective study.

Setting Tertiary neonatal intensive care unit.

Patients 78 prematurely born infants (median gestational age 29 (range 24–32) weeks) were studied; 39 developed BPD.

Interventions BPD was diagnosed as oxygen dependence at 28 days.

Main outcome measures Levels of a biological marker of inflammation (carbon monoxide) were assessed by measurement of end-tidal carbon monoxide (ETCO) and lung function by measurement of functional residual capacity (FRC) and compliance (Crs) and resistance (Rrs) of the respiratory system on days 3 and 14 after birth. Possible predictive factors were modelled for BPD and for BPD severity.

Results Gestational age, birth weight, ETCO, FRC and Crs results on days 3 and 14 differed significantly between infants who did and did not develop BPD. In multifactorial logistic regression, only birth weight and ETCO results (on day 14) remained significant predictors of BPD with an area under the curve of 0.97. The final multifactorial model for the severity of BPD included those two factors, plus septic episodes.

Conclusion These results emphasise the importance of ongoing inflammation in the development of BPD; ETCO levels, rather than lung function test results, were the more accurate predictor of BPD development.

Statistics from Altmetric.com

Footnotes

  • Funding CM was supported by the Charles Wolfson Charitable Trust. The Co-STAT equipment and consumables were donated by Natus Medical (San Carlos, California, USA).

  • Competing interests None.

  • Ethics approval This study was conducted with the approval of the King's College Hospital Research Ethics Committee.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.